Dr. Gregory Millette Buncke, MD

Dr. Buncke practices at California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby) in San Francisco, California.

Dr. Buncke's NPI, 1396736633, was assigned on November 4, 2005. Dr. Buncke graduated from Georgetown University School Of Medicine in 1981. Dr. Buncke holds California license G49617.

Dr. Buncke's primary practice is California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby), at 45 Castro St Lbby, San Francisco, CA 94114.

Dr. Buncke's primary practice is California Pacific Medical Ctr-Davies Campus Hosp - HOPD (45 Castro St Lbby) in San Francisco, California. Dr. Buncke is also affiliated with California Pacific Medical Center Davies Campus. The medical group on file is The Buncke Clinic. Dmand AI also links Dr. Buncke to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buncke practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Buncke's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Buncke is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Buncke is licensed in California.

Dmand AI lists head wound among the conditions Dr. Buncke treats.

CMS data shows 2,314 Medicare services from Dr. Buncke across 9 procedure codes in 2024, for 393 Medicare patients. Medicare paid $90,407 for them. Every service was in an office.

CMS counts 393 Medicare patients who saw Dr. Buncke in 2024. The largest group is 65 to 74, with 180 patients. 74% of them have high cholesterol, and 68% have arthritis. 4% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buncke's median patient age at 62, with 47% women.

In 2024, Dr. Buncke wrote 69 Medicare Part D claims for 28 patients. 99% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $2,565 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Buncke for performance year 2024, reported individually. Dr. Buncke accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 78 papers to Dr. Buncke, published from 2008 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Surgical Flaps, Microsurgery and Plastic Surgery Procedures. Dr. Buncke has published most often in Ann Plast Surg. Dr. Buncke's most frequent co-authors are Bauback Safa, Gabriel Matthew Kind, MD and Rudolf Fabian Buntic, MD.

Dmand AI links Dr. Buncke to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Peripheral Nerve Injuries and Peripheral Nervous System Diseases.

CMS Open Payments shows 303 general payments to Dr. Buncke from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. AxoGen paid the most, $187,531.

Dmand AI lists 5 awards for Dr. Buncke, most recently Regional Top Doctor in 2014.

Dr. Buncke graduated from Georgetown University School Of Medicine in 1981. Dr. Buncke is a member of ACS and ASPS.

Dr. Buncke is in network with 6 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.